(Q33393870)

26 July 2017

1 reference

title

Therapeutic apheresis in the treatment of hemolytic uremic syndrome in view of pathophysiological aspects (English)

1 reference

26 July 2017

1 reference

Rolf Bambauer

1

1 reference

26 July 2017

Reinhard Latza

series ordinal

2

1 reference

26 July 2017

Ralf Schiel

series ordinal

3

1 reference

26 July 2017

publication date

1 February 2011

1 reference

Therapeutic Apheresis and Dialysis

26 July 2017

published in

1 reference

26 July 2017

volume

15

1 reference

26 July 2017

issue

1

1 reference

26 July 2017

page(s)

10-19

1 reference

Haemolytic-uraemic syndrome: failure to demonstrate circulating endotoxin

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Therapy of the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Epidemic hemolytic-uremic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Adult hemolytic-uremic syndrome. Familial variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Clinical spectrum of postpartum renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Hemolytic Uremic Syndrome in Families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Spectrum of extrarenal involvement in postdiarrheal hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Therapeutic plasma exchange in the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Enterohaemorrhagic Escherichia coli in human medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Shiga toxin-mediated hemolytic uremic syndrome: time to change the diagnostic paradigm?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Escherichia coli O157:H7 Shiga toxin-encoding bacteriophages: integrations, excisions, truncations, and evolutionary implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Shiga toxin gene loss and transfer in vitro and in vivo during enterohemorrhagic Escherichia coli O26 infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Bacteriophage control of bacterial virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Hypocomplementemic autosomal recessive hemolytic uremic syndrome with decreased factor H.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Mitomycin-C nephrotoxicity: a clinico-pathologic study of 17 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Cisplatin-associated hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Two potential mechanisms of oxaliplatin-induced haemolytic anaemia in a single patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

An immediate hemolytic reaction induced by repeated administration of oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Cisplatin-associated hemolytic-uremic syndrome. Successful treatment with a staphylococcal protein A column

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Oxaliplatin-induced Evan's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Inhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Prostacyclin deficiency in haemolytic-uraemic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Prostanoids in hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Hemolytic uremic syndrome; pathogenesis, treatment, and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Fibrinolytic treatment of the haemolytic-uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Treatment of patients with microangiopathic haemolytic anaemia with heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Treatment of severe haemolytic-uraemic syndrome by dialysis (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Treatment of plasma refractory thrombotic thrombocytopenic purpura with protein A immunoabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Treatment of cancer chemotherapy-associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Therapeutic apheresis for cancer related hemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Plasma exchange and immunoadsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Combined plasmapheresis and hemodialysis treatment for severe hemolytic-uremic syndrome following Campylobacter colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Plasmapheresis as a therapeutic measure in hemolytic-uremic syndrome in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Guidelines on the use of therapeutic apheresis in clinical practice: evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Preliminary report: Treatment of the hemolytic-uremic syndrome with aspirin and dipyridamole

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Aspirin and dipyridamole therapy in the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Adult Hemolytic-Uremic Syndrome: Successful Treatment With Plasmapheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Plasma exchange using a continuous venovenous hemofiltration machine in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Prophylactic plasma exchange in CD46-associated atypical haemolytic uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Plasmapheresis in a child with the hemolytic-uremic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Clinical outcome in three patients with postpartum hemolytic uremic syndrome treated with frequent plasma exchange

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: a systematic review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1744-9987.2010.00903.X

10.1111/J.1744-9987.2010.00903.X

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference